GlassScriptPhysician profile
Ronald K Jaekle
NPI 1992704357
$470.02
in general payments reported to CMS, 2019-2025
9 companies · $233 in 2025
The $233 reported for 2025 was more than what 84% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.85 · 2023: $110 · 2024: $93.31 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $167.72 | 2024-2025 | Zurzuvae |
| Alexion Pharmaceuticals, INC. | $95.09 | 2022-2023 | Ultomiris |
| Organon LLC | $67.62 | 2024-2025 | Jada System |
| Shield Therapeutics INC | $44.52 | 2023-2024 | Accrufer |
| Acera Surgical, INC. | $22.57 | 2025 | Restrata Wound Matrix |
| Daiichi Sankyo INC. | $20.67 | 2023 | Injectafer |
| Pfizer INC. | $20.38 | 2025 | |
| Xeris Pharmaceuticals, INC. | $17.28 | 2024 | Gvoke Hypopen |
| Solventum Corporation | $14.17 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Jaekle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.